Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Withdrawn 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Gastrointestinal 1

Conditions

Lymphoma 540Precursor Cell Lymphoblastic Leukemia-Lymphoma 499Lymphoma, Non-Hodgkin 436Lymphoma, Follicular 403Leukemia, Lymphocytic, Chronic, B-Cell 389Lymphoma, Large B-Cell, Diffuse 385Lymphoma, B-Cell 247Lymphoma, Mantle-Cell 223Hodgkin Disease 208Recurrence 204Leukemia, Myeloid, Acute 197Leukemia 192Multiple Myeloma 184Burkitt Lymphoma 182Lymphoma, B-Cell, Marginal Zone 170Neoplasms 152Myelodysplastic Syndromes 132Hematologic Neoplasms 115Waldenstrom Macroglobulinemia 103Lymphoma, T-Cell, Peripheral 85Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 81Lymphoma, T-Cell 81Lymphoma, T-Cell, Cutaneous 66Leukemia, Myelogenous, Chronic, BCR-ABL Positive 62Mycosis Fungoides 57Leukemia, Biphenotypic, Acute 54Breast Neoplasms 54Myeloproliferative Disorders 50Leukemia, B-Cell 50Lymphoproliferative Disorders 47

Interventions

Therapeutics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Constriction, Pathologic × Lymphoid × 1 year × Clear all
NCT05149755 2026-05-19

Evolutâ„¢ EXPAND TAVR II Pivotal Trial

Medtronic Cardiovascular

Phase NA Active not recruiting
650 enrolled
Lymphoid

Constriction, Pathologic, Lymphoma, Follicular

NCT07060183 2025-07-11

Aortic Valve Replacement for Moderate Aortic Stenosis With Left Ventricular Decompensation Early Feasibility Study

Dermed Diagnostics, Inc.

Phase NA Withdrawn
Lymphoid

Constriction, Pathologic, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡